Seroprevalence and risk factors of hepatitis a virus infection in Iran: A population based study

Archives of Iranian Medicine

Volumn 13, Issue 2, 2010, Pages 99-104

  Merat, Shahin ^a   Rezvan, Houri ^b   Nouraie, Mehdi ^a,c   Abolghasemi, Hassan ^d   Jamali, Raika ^a   Amini Kafiabad, Sedigheh ^b   Maghsudlu, Mahtab ^b   Pourshams, Akram ^a   Malekzadeh, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^c HOWARD UNIVERSITY   (United States)

^d BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatitis A; Iran; Prevalence; Seroepidemiologic studies

Indexed keywords

HEPATITIS A ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; EDUCATIONAL STATUS; FATHER; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; INFECTION RISK; INTERVIEW; IRAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; SEROPREVALENCE; SEX DIFFERENCE; URBAN RURAL DIFFERENCE;

EID: 77949371471     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect. 2004; 132: 1005-1022.
2. Hendrickx G, Van Herck K, Vorsters A, Wiersma S, Shapiro C, Andrus JK, et al. Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology. J Viral Hepat. 2008; 15 (suppl 2): 1-15.
3. Melnick JL. History and epidemiology of hepatitis A virus. J Infect Dis. 1995; 171 (suppl 1): S2-S8.
4. Centers for Disease Control and Prevention. Hepatitis Surveillance Report No. 58. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. 2003: 1
5. Koff RS. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine. 1992; 10 (suppl 1): S15-S17.
6. Lednar WM, Lemon SM, Kirkpatrick JW, Redfield RR, Fields ML, Kelley PW. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol. 1985; 122: 226-233.
7. Farzadegan H, Shamszad M, Noori-Arya K. Epidemiology of viral hepatitis among Iranian population-a viral marker study. Ann Acad Med Singapore. 1980; 9: 144-148.
8. Pourshams A, Saadatian-Elahi M, Nouraie M, Malekshah AF, Rakhshani N, Salahi R, et al. Golestan cohort study of oesophageal cancer: feasibility and first results. Br J Cancer. 2005; 92: 176-181.
9. Jacobsen KH, Koopman JS. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol. 2005; 34: 600-609.
10. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med. 2009; 12: 225-231.
11. Malekzadeh R, Khatibian M, Rezvan H. Viral hepatitis in Iran and the world: epidemiology, diagnosis, treatment, and prevention (in Persian). J Med Council Irn. 1997; 15: 183-200.
12. Elikaei A, Sharifi Z, Shooshtari MM, Hosseini M, Maroufi Y. Prevalence of HAV among healthy blood donors referring to Tehran transfusion center. Iranian J Publ Health. 2008; 37: 126-130
13. Mehr AJ, Ardakani MJ, Hedayati M, Shahraz S, Mehr EJ, Zali MR. Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran. Eur J Epidemiol. 2004; 19: 275-278
14. McQuillan GM, Kruszon-Moran D, Kottiri BJ, Curtin LR, Lucas JW, Kington RS. Racial and ethnic differences in the seroprevalence of 6 infectious diseases in the United States: data from NHANES III, 1988-1994. Am J Public Health. 2004; 94: 1952-1958.
15. Webb PM, Knight T, Greaves S, Wilson A, Newell DG, Elder J, et al. Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life. BMJ. 1994; 308: 750-753.
16. Moreira ED Jr., Nassri VB, Santos RS, Matos JF, de Carvalho WA, Silvani CS, et al. Association of Helicobacter pylori infection and giardiasis: results from a study of surrogate markers for fecal exposure among children. World J Gastroenterol. 2005; 11: 2759-2763
17. Nouraie M, Latifi-Navid S, Rezvan H, Radmard AR, Maghsudlu M, Zaer-Rezaii H, et al. Childhood hygienic practice and family education status determine the prevalence of Helicobacter pylori infection in Iran. Helicobacter. 2009; 14: 40-46.
18. Pretolani S, Stroffolini T, Rapicetta M, Bonvicini F, Baldini L, Megraud F, et al. Seroprevalence of hepatitis A virus and Helicobacter pylori infections in the general population of a developed European country (the San Marino study): evidence for similar pattern of spread. Eur J Gastroenterol Hepatol. 1997; 9: 1081-1084
19. Webb PM, Knight T, Newell DG, Elder JB, Forman D. Helicobacter pylori transmission: evidence from a comparison with hepatitis A virus. Eur J Gastroenterol Hepatol. 1996; 8: 439-441
20. Gentile A. The need for an evidence-based decision-making process with regard to control of hepatitis A. J Viral Hepat. 2008; 15 (suppl 2): 16-21.
21. Wasley A, Fiore A, Bell BP. Hepatitis A in the era of vaccination. Epidemiol Rev. 2006; 28: 101-111
22. Das A. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries. Hepatology.1999; 29: 548-552.